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Viral infections are ubiquitous in humans, animals, and plants. Real-time methods to 
identify viral infections are limited and do not exist for use in harsh or resource-constrained 
environments. Previous research identified that tissues produce unique volatile organic 
compounds (VOC) and demonstrated that VOC concentrations change during pathologic 
states, including infection, neoplasia, or metabolic disease. Patterns of VOC expression 
may be pathogen specific and may be associated with an odor that could be used for 
disease detection. We investigated the ability of two trained dogs to detect cell cultures 
infected with bovine viral diarrhea virus (BVDV) and to discriminate BVDV-infected cell 
cultures from uninfected cell cultures and from cell cultures infected with bovine herpes 
virus 1 (BHV 1) and bovine parainfluenza virus 3 (BPIV 3). Dogs were trained to recognize 
cell cultures infected with two different biotypes of BVDV propagated in Madin–Darby 
bovine kidney cells using one of three culture media. For detection trials, one target and 
seven distractors were presented on a scent wheel by a dog handler unaware of the 
location of targets and distractors. Detection of BVDV-infected cell cultures by Dog 1 
had a diagnostic sensitivity of 0.850 (95% CI: 0.701–0.942), which was lower than Dog 
2 (0.967, 95% CI: 0.837–0.994). Both dogs exhibited very high diagnostic specificity 
(0.981, 95% CI: 0.960–0.993) and (0.993, 95% CI: 0.975–0.999), respectively. These 
findings demonstrate that trained dogs can differentiate between cultured cells infected 
with BVDV, BHV1, and BPIV3 and are a realistic real-time mobile pathogen sensing 
technology for viral pathogens. The ability to discriminate between target and distractor 
samples plausibly results from expression of unique VOC patterns in virus-infected and 
-uninfected cells.
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inTrODUcTiOn
Globally, infectious diseases continue to be leading causes of morbidity and mortality. Efforts to 
control infectious disease in human, animal, and plant populations would benefit from real-time 
screening technologies, which could be effectively deployed in areas of strategic interest for pathogen 
transmission. Current surveillance methods rely on the collection of diagnostic samples from indi-
viduals or contaminated environments, transportation of samples to a laboratory, and subsequent 
laboratory testing to demonstrate the presence of the pathogen of interest, resulting in a significant 
delay in response times and containment efforts. Development of a sensitive, easily deployable 
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real-time mobile pathogen sensing technology (RMST) would 
be useful in border security, public health, wildlife management, 
and agriculture to aid in the detection and containment of disease 
outbreaks and to prevent acts of bioterrorism and agro terrorism.
The abilities of trained dogs to identify odors associated with 
explosives and munitions in operational environments are supe-
rior to other currently available detection technologies. The highly 
sensitive canine olfactory sensory system can detect some target 
substances at concentrations as low as parts per trillion (1), three 
orders of magnitude more sensitive than available instruments 
which reliably identify substances at concentrations of parts per 
million or billion. Canine detection systems are inherently mobile 
and can trace an odor to its source. To be comparable to the 
detection ability of dogs, a detection system would need to be (1) 
extraordinarily sensitive, (2) mobile, and (3) able to move toward 
a target source. No currently available system meets those criteria. 
If dogs can be trained to detect odors associated with specific 
pathogens, canine-based RMST systems could provide a method 
for pathogen detection in frontline operational environments and 
complement the development of detection instrumentation for 
pathogen detection, analytical chemistry, and metabolomics.
Pathogen Biomarkers for scent Detection
Strong scientific evidence supports the release of stable volatile 
organic compounds (VOC) from tissues that are present in 
exhaled breath, urine, feces, and sweat. The VOC that are released 
are known as the volatilome (2). VOC are volatile at ambient 
temperatures, may be associated with an odor, and may provide 
the continuous signal needed for real-time detection (3).
Tissues infected with pathogens release unique volatile 
metabolic biomarkers, which become part of detectable VOC 
disease signatures (4, 5). Disease-specific VOC show potential 
for use in medical diagnosis and therapeutic monitoring (2). 
Multiple studies demonstrated that VOC patterns may be unique 
to a specific pathogen or an infection with a specific pathogen. 
In a review of 31 publications, Bos et al. (6) concluded that many 
pathogenic bacteria have distinct metabolisms that produce 
species-specific VOC and suggested that the presence of these 
VOC in patients indicated infection. In a cell culture model, 
Schivo et al. (7) demonstrated different VOC expression patterns 
in primary human tracheobronchial cells infected or uninfected 
with human rhinovirus. Aksenov et al. (8) determined that VOC 
produced by B lymphoblastoid cells following infection with 
three live influenza virus subtypes were unique for each virus 
subtype. In addition, Abd El Qader et al. (9) examined the VOC 
released from cultures of five viruses (influenza A, influenza B, 
adenovirus, respiratory syncitial virus, and parainfluenza 1 virus) 
and four bacteria (Moraxella catarrhalis, Haemophilus influenza, 
Legionella pneumophila, and Mycoplasma pneumoniae). The 
researchers detected 12 and 6 VOC that were associated with 
bacterial and viral growth and identified 2 VOC that were differ-
entiated between bacterial and viral infection (9). Lastly, Mashir 
et al. (10) administered live attenuated H1N1 vaccine (FluMist®) 
to humans and demonstrated that exhaled breath VOC increased 
for 7 days after the vaccination. These studies suggest that unique 
VOC profiles associated with viral pathogens exist and that they 
may be detected in patients. If pathologic processes such as 
infections, neoplasia, and metabolic disorders influence the type, 
ratio, and strength of VOC emitted from a biological system, then 
unique VOC patterns may create a specific signature odor (11). 
Currently, VOC analysis requires expensive and sophisticated 
stationary analytical chemical instrumentation, such as gas 
chromatography–mass spectrometry.
Dogs as a Pathogen and Disease sensor
Trained dogs have consistently demonstrated value as sensitive 
real-time chemical sensing detectors for narcotic, explosive, and 
select biological targets. Similarly, dogs have been used to detect 
disease biomarkers in humans, including cancer and bacterial 
infections. Potential VOC biomarker concentrations are reported 
to be in the part per billion to part per trillion range for breath and 
part per million to part per billion range in blood and urine (12). 
Canids are capable of detecting some substances in concentra-
tions as low as parts per trillion (1). Therefore, VOC biomarkers 
are within the detection range of the canine olfaction system. 
In some cases, dogs have been able to detect disease states in 
exhaled breath that contains the lowest known VOC concentra-
tions. Sonoda et al. (13) trained a dog to detect human patients 
with colon cancer using samples of exhaled breath and watery 
stool. The dog’s sensitivity and specificity for cancer detection in 
breath samples were 0.91 and 0.99, respectively. The sensitivity 
and specificity for detection in stool samples were 0.97 and 0.99, 
respectively (13).
Another study demonstrated that the overall sensitivity of 
canine scent detection of lung cancer utilizing exhaled breath 
samples was 0.99, with a specificity of 0.99 (14). In the same 
report utilizing trained dogs to evaluate breath samples from 
breast cancer patients and controls, the sensitivity of detection 
was 0.88 and specificity was 0.98 (14). These reports suggest that 
VOC or similar compounds from diseased internal tissues are 
released externally and may be detected on the body or in the 
surrounding air with the aid of trained dogs with a high degree 
of diagnostic accuracy.
Pathogen detection methods utilizing the keen canine sense of 
smell may offer a viable option for developing a rapidly deploy-
able disease screening tool and provide valuable information 
about a subject’s pathophysiological condition (3, 15). The use 
of trained detection dogs offers certain inherent advantages. 
Unlike a deployable instrument, dogs can examine thousands of 
samples or scan large surface areas efficiently, which is important 
in detecting pathogens in large herds of animals, crowds of 
people, objects (e.g., ships, airplanes, buildings), or areas of land. 
Diagnostic testing using laboratory instrumentation in an opera-
tional environment is often impeded by the lack of cleanliness, 
interference by air particulates, presence of non-target VOC pro-
duced by various substances in the environment, and constantly 
changing variables, such as temperature, humidity, wind, and 
thermal plumes. By contrast, purpose-bred detection dogs have a 
demonstrated ability to search for unique odor patterns and iden-
tify specific targets in field conditions amidst substantial “odor 
noise” (i.e., varied and/or strong odors). Although at least 381 
unique VOC are emitted from human feces (2), a trained dog was 
able to detect Clostridium difficile in human stool samples (16). 
The dog detected C. difficile with high diagnostic sensitivity and 
TaBle 1 | Target viruses (BVDV aU526 and BVDV naDl) and distractor viruses (BhV 1 and BPi 3) were propagated on Madin–Darby bovine kidney 
(MDBK) cells using one of three media.
Targets Distractors
1A (n = 19): BVDV AU526 (non-cytopathic) + MDBK + eQs (SPT = 3) 1B = MDBK + eQs
2A (n = 21): BVDV AU526 (non-cytopathic) + MDBK + FBs (SPT = 1) 2B = MDBK + FBs
3A (n = 15): BVDV AU526 (non-cytopathic) + MDBK + EQS + gentamicin (SPT = 2) 3B = MDBK + eQs + gentamicin
4A (n = 2): BVDV NADL (cytopathic) + MDBK + eQs (SPT = 0) 7A = BhV-1 (cytopathic) + MDBK + eQs
5A (n = 2): BVDV NADL (cytopathic) + MDBK + FBS (SPT = 1) 8A = BhV-1(cytopathic) + MDBK + FBs




While cell culture media 1, 3, 4, and 6 contained equine serum (EQS), fetal bovine serum (FBS) was used in the preparation of medium 2 and 5. Cell culture medium 3 and 6 were 
prepared using the antibiotic gentamicin as an additional distractor. The n values represent the total number of samples used in the target column and the SPT values equal the total 
number of search past targets for each sample. The underlined text emphasizes the different characteristics of the two strains of BVDV that were used; the text in bold emphasizes 
differences among the three types of media.
January 2016 | Volume 2 | Article 793
Angle et al. Virus Detection Dogs
Frontiers in Veterinary Science | www.frontiersin.org
specificity in stool samples and hospitalized patients, correctly 
identifying 25 of the 30 C. difficile cases and 265 of 270 control 
cases (16). This emphasizes the dog’s ability to detect a specific 
odor pattern among the myriad of odors from other bacteria, 
fungi, and viruses naturally present in feces.
There are no reported attempts to train dogs to detect viral 
pathogens. Detection of infection or disease by trained dogs could 
provide advantages over other VOC detection technologies such 
as mass spectrometry by providing a real-time binary response, 
avoiding the need for trained personnel in the processing and 
interpretation of mass spectrometry samples, and avoidance of 
testing-associated delays in response efforts. Dogs are mobile, 
adapted to difficult work environments, can track a plume of 
airborne target material to its source and can eliminate the need 
to collect and transport surface or air samples to a centralized 
laboratory. If dogs can be trained to locate target pathogens, they 
could be employed to detect pathogens or be deployed at strategic 
locations to prevent entry and transmission of disease.
The use of dogs to detect odors associated with viral infection 
and sensitivity and specificity of a canine detection model has not 
been described. The purpose of this study was to evaluate the abil-
ity of trained dogs to detect viral pathogen-associated odors in 
real-time, alert a handler to the presence of these pathogens, and 
discriminate those odors from those associated with other viral 
pathogens. Specifically, we examined the dog’s ability to identify 
bovine viral diarrhea virus (BVDV) infected cell cultures and to 




Two healthy adult male Labrador Retrievers were trained to 
detect BVDV-infected cell cultures. The dogs were purpose-bred 
for detection work from a colony of detection dogs developed at 
the Auburn University Canine Performance Sciences Breeding 
Program. Each dog had over 3 years of operational experience as 
an explosives detection dog in our Canine Performance Sciences 
Research Program. The dogs were selected based on their previ-
ous experience as explosives detection dogs and because they 
had calculated and methodical microsearch techniques that are 
important for the detection of viral targets. The dogs received 
2 months of proprietary viral target detection training prior to 
data collection. The dogs were trained by a Master Detection Dog 
Trainer who had over 35 years of experience training detection 
dogs. The dogs were trained in a Bio Safety Lab Level 2 (BSL2) 
during the training period and received up to 15–30 trials per day, 
4–5 days/week. All activities for this project were approved by an 
Institutional Animal Care and Use Committee and a Biological 
Use Authorization was granted by an Institutional Biosafety 
Committee.
Testing apparatus
A 12 × 12 foot, climate and humidity controlled, indoor, BSL2 
isolation room was used for scent testing. In the center of the 
room was a scent wheel with eight arms that are designed to 
each hold a small metal basket. For each trial, one target odor 
and seven distracting odors (or eight distracting odors for blank 
trials) (Table 1) were each placed in separate glass Petri dishes, 
covered by a mesh screen, and then individually placed in a metal 
basket, one per arm of the scent wheel. All target odors were ran-
domly assigned a position (1–8) on the scent wheel. Dogs were 
brought into the room and allowed to search, starting at position 
1 and working to position 8. When the dog found the target odor, 
it alerted by sitting, and was rewarded with a toy.
Targets and Distractors
Bovine viral diarrhea virus (BVDV) was chosen as the target 
virus, because it provides a pathogen model that has been 
extensively studied and is easily propagated in different types 
of cells and media and is not pathogenic to humans or dogs. A 
non-cytopathic strain of BVDV (1b AU526) and a cytopathic 
strain of BVDV (1a NADL) were used as target viruses. The 
BVDV targets were propagated in Madin–Darby bovine kidney 
(MDBK) cells using one of three variations of culture media. 
The dogs were presented with 0.5 ml of target sample contain-
ing either cytopathic or non-cytopathic BVDV [1 × 105–1 × 106 
CCID50 (cell culture infective doses, 50% endpoint)/ml]. The 
distractor viruses used in this study were bovine herpesvirus 1 
(BHV 1) Colorado strain and bovine parainfluenza virus 3 (BPIV 
TaBle 2 | individual dog results.
Dog 1 Dog 2
Sensitivity 0.85 0.967
Specificity 0.981 0.993
Total number of search past targets (i.e., misses) 6 1
Total number of positive indications 28 30
Total number of positive trials 34 31
Total number of blank trials (i.e., no BVDV present) 24 20
Total number of negative samples searched 317 287
Total number of false indications 6 2
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3) SF/4. Preparation of all samples was performed by the same 
laboratory technician wearing identical nitrile gloves to prevent 
odor differences among samples caused by differences in sample 
handling. Target and distractor viruses were propagated in 75 cm2 
cell culture flask that had been seeded with MDBK cells 24  h 
earlier. Three hundred microliters of stock virus were added to 
each flask in 3 ml of media. Cell culture media contained purified 
water, Minimal Essential Media with Earle’s salts (GIBCO® MEM, 
10×, 11430, Thermo Fisher Scientific, Life Technologies, Grand 
Island, NY, USA), l-glutamine [GIBCO® l-glutamine (200 mM), 
Thermo Fisher Scientific, Life Technologies, Grand Island, NY, 
USA], PSF [GIBCO® Antibiotic-Antimycotic (100×), Thermo 
Fisher Scientific, Life Technologies, Grand Island, NY, USA], 
sodium bicarbonate (GIBCO® Sodium Bicarbonate 7.5% solu-
tion, Thermo Fisher Scientific, Life Technologies, Grand Island, 
NY, USA), and serum. Three different cell culture media were 
prepared that differed either in the type of serum added (equine 
serum (1 and 4) or fetal bovine serum (FBS) (2 and 5)), or con-
tained gentamicin as an additional antibiotic (3 and 6). Following 
1 h of adsorption, 20 ml of additional medium was added. Flasks 
were incubated until cytopathic effect in approximately 60% of 
cells was observed (BVDV 1 NADL, BHV 1, and BPI 3) or for 
3  days when propagating the non-cytopathic BVDV AU526. 
Virus was harvested by a single freeze–thaw cycle by placing the 
flask in a −80°C freezer. Following thawing, contents of each flask 
were aliquoted into plastic snap-top tubes and stored (−80°C) 
until needed. Virus-free distractor samples underwent identical 
preparation including 24 h incubation prior to addition of 20 ml 
of media, incubation for 2–3 days following addition of media, 
and submission to a single freeze–thaw cycle prior to aliquot-
ing and storage. For training and testing of dogs, 0.5 ml of each 
sample was placed into glass Petri dishes.
Distractors, or “non-target odors,” are used to provide scents 
that are similar to or slightly different than the positive target 
to ensure that the dog is truly indicating on the positive target. 
Distractors in this study are listed in Table 1.
The duration of exposure to target and non-target odors was 
very short, typically <0.25 s (i.e., the amount of time needed to 
sniff a basket), and determined by individual dog search behavior; 
dogs were never manually forced to sample the vapor from any 
target source (i.e., the dog is always free to repel from the source 
of the odor). The dogs typically searched all eight scent wheel 
positions in 3.5–4.0 s. Targets and distractors were presented in a 
manner to prevent dogs from physically contacting or ingesting 
the sample.
Extensive efforts were made to reduce confounding factors that 
could lead to false positive results or inflated measures of detec-
tion performance unrelated to detection/non-detection of the 
virus odor outside that of the dog smelling the target virus odor. 
Only one target sample was used per trial and its position among 
the eight arms of the scent wheel on each trail was randomly 
assigned. One hundred percent of targets and distractors and their 
holding containers were changed after each trial. Baskets, basket 
holders, scent wheel apparatus, and Petri dishes were only handled 
using nitrile gloves and metal forceps to eliminate human scent. 
Baskets were sanitized on high heat at least daily in a commercial 
dishwasher, without soap. All targets and distractors were handled 
by the same person to eliminate the dog’s ability to identify a single 
person associated with the target. Each arm of the scent wheel 
is identical to negate any visual cues that may enable detection 
capabilities. Dogs were monitored for characteristic changes in 
behavior related to detection of a target odor, including pausing 
and turning head abruptly at a position or emitting its trained final 
response of sitting at a target. All dogs were operated off lead by 
the handler. The dogs where handled by a Lead Canine Instructor 
who had 6 years of canine training and handling experience. This 
canine instructor did assist in training the dogs for this project. 
The handler was blinded to the target location and upon releasing 
the dog into the room, the handler stood at the door and stared 
straight ahead to avoid influencing the dog. If the dog indicated 
on a basket, the test moderator who was in the test room told the 
handler to reward or withhold the reward. This process insured 
that the dogs were not rewarded for indicating on a distractor 
virus and then being subsequently imprinted on the distractor 
virus because it received its reward. Blank trials contained eight 
distractors and no BVDV. Blank trials were utilized to insure that 
the dogs did not find a live target every time they searched the 
scent wheel, which reduces the propensity of the dog to alert to the 
final position regardless of whether it contains a target.
The dogs were taught to search position 1 to position 8 and 
then exit the room. The test moderator at the end of the trial 
notated the number of distractors that the dog searched in each 
trial. This provided the ability to calculate the total number of 
distractors searched by the dog.
Data analysis
Search results for each trial were recorded and entered into a 
spreadsheet (Microsoft Excel, Microsoft, Redmond, WA, USA). 
The sensitivity, specificity, and associated 95% confidence intervals 
were calculated using an online calculator (http://vassarstats.net).
resUlTs
The results for this study are shown in Table 2. Dog 1 alerted to 28 
of 34 total target presentations and emitted 6 alerts across a total 
of 317 distractor presentations. Dog 2 alerted to 30 of 31 total 
target presentations and emitted 2 alerts across a total of 287 dis-
tractor presentations. The diagnostic sensitivity of Dog 1 [0.850, 
95% confidence interval (CI): 0.701–0.942] was lower than that 
of Dog 2 (0.967, 95% CI: 0.837–0.994), and both dogs exhibited 
very high diagnostic specificity (0.981, 95% CI: 0.960–0.993) and 
(0.993, 95% CI: 0.975–0.999), respectively.
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A total of 65 positive and 44 blank (i.e., no BVDV present) 
trials were conducted. Each trial had a possibility of up to seven or 
eight distractors. There were 109 total trials in the study and after 
back calculating for the total number of distractors experienced, 
there were 604 distractors encountered by the dogs. There were 
eight total false responses that occurred while discriminating the 
604 distractors used during this study. This demonstrates that the 
dogs did discriminate a large number of distractors and main-
tained a high rate of specificity. The dogs did not alert on seven 
targets and false responded on eight distractors. No search past 
target was attributed to a specific target (i.e., type of BVDV, see 
Table 1). Data for false responses were not collected for a specific 
distractor; therefore, it is unknown if the dogs false responded on 
any one distractor. Observations made by the test moderator were 
that the dogs false indicated on multiple distractors.
DiscUssiOn
We hypothesized that dogs were able to detect and differentiate 
BVDV-infected cell cultures utilizing odors associated with dif-
ferent VOC expression patterns. Several recent reports indicate 
that cellular infections with viruses are associated with unique 
profiles of VOC (7–10, 17), but no published studies equate these 
VOC with an odor that is detectable by trained dogs. In this study, 
we were able to train dogs to discriminate cell cultures infected 
with BVDV from uninfected cell cultures and from cell cultures 
infected with one of two other viruses demonstrating the potential 
to detect the presence of odors associated with a target virus. The 
detection and discrimination of infected cell cultures by trained 
dogs supports our hypothesis of a unique odor profile associated 
with BVDV infection. As detection by the dog is immediate, 
this method has potential for use in real-time detection of viral 
pathogens in field situations.
Biochemical mechanisms underlying the release of disease-
related VOC are largely unknown (4, 5, 12). No published studies 
define which, if any, VOC are detectable as an odor by dogs and 
the identity of the substances which alerted our dogs to infection 
is speculative. It is possible that VOC profiles associated with 
viral infections are analogous to the odor profile detected by our 
dogs. Previous studies demonstrated that compounds induced by 
pathogen infection may be detected as an odor (11), but current 
chemical analytical techniques have not defined the full odor 
profile which would control the alerting behavior of a dog.
Our study utilized purpose-bred detection dogs and training 
methods proven to be successful for the detection of other target 
substances, such as explosives. To the best of our knowledge, no 
previous attempts to detect and discriminate viral targets utiliz-
ing trained dogs have been made. The sensitivity and specificity 
of detection in the current study are similar to studies using 
dogs to detect the presence of neoplastic disease. Two studies 
evaluating the ability of dogs to detect prostate cancer-associated 
compounds in urine have yielded conflicting results. Elliker et al. 
(18) reported that trained dogs did not generalize on a prostate 
cancer odor and did not alert to new cancer samples following 
training on 50 unique prostate cancer samples and 67 controls. 
However, this study did not use purpose-bred detection dogs and 
the dogs lacked any previous detection experience. By contrast, 
Cornu et al. (19) trained a single dog to alert to positive prostate 
cancer samples with a sensitivity of 0.91. The differing results 
suggest that training methods, individual canine capabilities, and 
trial evaluations can affect outcomes and must be rigorous and 
scientifically sound to allow valid conclusions.
Results of our study suggest that trained dogs have the poten-
tial to function as a highly sensitive, highly specific, and mobile 
sensory technology to detect pathogen targets. Trained dogs 
could bridge the gap in pathogen and disease detection until other 
technologies are developed. The use of trained detector dogs has 
proven to be successful as a real-time mobile sensory technology 
in many inclement environments in the world during military, 
police, rescue, and other operations. Conversely, current ana-
lytical technologies capable of detecting diseases or pathogens in 
real-time in operational scenarios are unavailable, and there is no 
reported technology that can follow odor to its source like a dog.
Limitations of the current study include the use of cell 
culture-derived BVDV, use of a small number of trained dogs, a 
single-blind experiment, and the completion of the experiment in 
a climate-controlled environment. We did not evaluate the lowest 
level of detection of BVDV; however, our 0.5 ml samples of cell 
cultures were well within the range of detection by the dogs. We do 
not know at what level the sample becomes undetectable. Future 
research should focus on multiple target viruses, utilize a greater 
number of trained canids, and include a greater number of distrac-
tors. The test moderator was in the BSL2 with the dog making this 
a single-blind experiment. It is not known if the dog or handler was 
influenced by the moderator’s knowledge of the target position and 
how that may/may not have influenced the results. The dogs were 
off lead and the only command given by the handler was to “come” 
(i.e., out of the BSL2 room). Future projects should be conducted 
in a double-blind fashion. Virus detection should be conducted in 
different environmental conditions to assess the effects of tempera-
ture and humidity on sensitivity and specificity. The ability of dogs 
trained on cell culture-derived BVDV to correctly identify samples 
collected from infected hosts should be explored to determine if 
dogs can successfully detect viral infection utilizing a variety of 
sample types (e.g., breath, nasal discharge, sweat, and saliva).
The potential for detector dogs or their handlers becoming 
infected or harmed by a potential pathogen or transmitting the 
pathogen should be considered. Specific target viruses selected 
for study should be evaluated for risk to the detector dogs or 
transmission to humans, animals, and plants.
cOnclUsiOn
Our study indicates that dogs can detect and discriminate virus-
infected cell cultures. Apparently, unique odors associated with 
viral infections allow the dogs to obtain high rates of sensitivity and 
specificity. This finding demonstrates the potential for utilizing dogs 
to detect pathogens in real-time, which would be useful to identify 
or contain pathogen outbreaks, deter acts of bioterrorism, facilitate 
immediate treatment and containment of pathogen outbreaks, 
and reduce the need to transport samples for laboratory testing. 
Given that this demonstrated capability of dogs to detect odors 
associated with viruses and act as a RMST, additional research and 
development are warranted. In addition, dogs offer a platform for 
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discovery to advance disease and chemical sensing machine tech-
nologies. Dogs provide a three order of magnitude more sensory 
capacity than most current diagnostic instruments. Therefore, they 
could be used for identifying specific VOC biomarkers related to 
disease which could aid metabolomics discoveries in other fields, 
such as analytical chemistry and wildlife biology.
Manufacturer information
 a Corning® cell culture flask, Corning Inc., Corning, NY, USA.
 b GIBCO® MEM, 10×, 11430, GIBCO by Life Technologies 
Corp., Grand Island, NY, USA.
 c Seradigm, Providence, UT, USA.
 d HyClone Laboratories Inc., Logan, UT, USA.
 e GIBCO® l-glutamine (200 mM), GIBCO by Life Technologies 
Corp., Grand Island, NY, USA.
 f GIBCO® Antibiotic-Antimycotic (100×), GIBCO by Life 
Technologies Corp., Grand Island, NY, USA.
 g GIBCO® Sodium Bicarbonate 7.5% solution, GIBCO by Life 
Technologies, Grand Island, NY, USA.
 h Gentamicin sulfate powder, AMRESCO, Solon, OH, USA.
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